Sunday, July 12, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 63 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 8815866

    Aminopyridine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted

  2. US 8816046

    Compositions and methods for CaMKII inhibitors and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted

  3. US 8815951

    Inhibitors of epoxide hydrolases for the treatment of inflammation

    The Regents of the University of California · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted

  4. US 8815928

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted

  5. US 8809335

    Pyrazolopyrimidine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted

  6. US 8809364

    Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted

  7. US 8809377

    Deubiquitinase inhibitors and methods for use of the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted

  8. US 8809347

    Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as AXL inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted

  9. US 8809264

    Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted

  10. US 8802733

    Aldehyde dehydrogenase inhibitors as novel depigmenting agents

    The Board of Regents of the University of Texas System · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted

  11. US 8802695

    Apoptosis signal-regulating kinase 1 inhibitors

    Takeda Pharmaceutical Company Limited · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted

  12. US 8796008

    Influenza A virus vaccines and inhibitors

    The Board of Regents of the University of Texas System · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  13. US 8796259

    N3-heteroaryl substituted triazoles and N5-heteroaryl substituted triazoles useful as axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  14. US 8785429

    Dihydropyrrolonaphthyridinone compounds as inhibitors of JAK

    Takeda Pharmaceutical Company Limited · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  15. US 8785444

    Thiazoles and pyrazoles useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  16. US 8785377

    Tetrazolyl macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  17. US 8785487

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  18. US 8778938

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  19. US 8779001

    Stat3 inhibitors

    The United States of America Dept. of Health and Human Services (DHHS) · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  20. US 8778980

    Heterocyclic aspartyl protease inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  21. US 8779197

    Aryl amides useful as inhibitors of voltage-gated sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  22. US 8778876

    Small-molecule inhibitors of Dengue and West Nile virus proteases

    The Board of Regents of the University of Texas System · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  23. US 8771665

    Inhibitors of hepatitis C virus polymerase

    COCRYSTAL, DISCOVERY, INC. · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted

  24. US 8772288

    Substituted spiro[cycloalkyl-1,3′-indo]-2′(1′H)-one derivatives and their use as P38 mitogen-activated kinase inhibitors

    Almirall, S.A. · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.